Home » Newsletters » The Carlat Child Psychiatry Report

The Carlat Child Psychiatry Report

Early Childhood Psychiatry (October/November/December) | 2024

View Archived Issues

Learning Objectives, Early Childhood Psychiatry, CCPR, October/November/December 2024

October 1, 2024

After reading these articles, you should be able to…

Dysregulation in Autism: Irritability, Aggression, and “Pathological Demand Avoidance”

October 1, 2024

Alyssa Aikman, MSN, APRN, PMHNP-BC

Pathological demand avoidance (PDA) is a popular concern among autistic kids and families. It’s not in the DSM, yet we need to understand and address it. This clinical update helps you approach irritability and PDA rationally to help autistic patients connect and regulate before merely prescribing D2-blocking antipsychotics.

Treating ADHD in Young Children

October 1, 2024

Natalie Pon, MD

What does ADHD look like in young children? How do we differentiate it from just another active toddler? And if a young child really does have ADHD, how do we treat it? Our interview with Dr. Natalie Pon will help you identify and treat ADHD in young children.

Practical Advocacy in Child and Adolescent Psychiatry

October 1, 2024

Abishek Bala, MD, MPH

We all want to offer comprehensive care that includes every team member: therapists, teachers, parents, and even the child. This is a daunting task, and our clinical update gives you the reasoning to share and the ideas you can use to pursue this ideal with your patients and their families.

Early Childhood Psychiatric Care

October 1, 2024

Jeffrey Rowe, MD

Mental health problems in young children are incredibly complex. Dr. Jeffrey Rowe’s comprehensive outline helps us organize our assessment and care planning for these children. Even more important, since most of us see older kids, Dr. Rowe helps us find the links between problems in early childhood and later mental health challenges.

Stimulants in Preschool-Age Children

October 1, 2024

Earth Hasassri, MD

We are understandably hesitant to treat young children with medication for ADHD. Does it work? Will there be worse or different side effects? This research update will help you weigh the risks and benefits of pursuing stimulant treatment for ADHD in our smallest patients.

How Safe Is Methylphenidate?

October 1, 2024

Earth Hasassri, MD

Most of us use methylphenidate (MPH) routinely in patients across a wide range of ages and even diagnoses. But what are the long-term side effects of MPH? This research update gives you a current understanding of the potential risks with helpful guidance on how to proceed with care.